Treace Medical Continues Gains Across Key Metrics

Treace Medical reported 2Q22 orthopedic sales of $30 million, +45.1% compared to 2Q21.

The company estimates that it has penetrated 20% of the 10,000 foot-and-ankle surgeons in the U.S. who perform bunion surgery. Utilization increased to 10.1 kits per surgeon in the second quarter, compared to 9.8 a year ago. Average blended selling price...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us